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INTRODUCTION
Solid tumors are highly complex tissues consisting of cancer cells, vascular endothelial cells, fibroblasts, immune cells, and stromal cells.
1) The formation of complex tissues is implicated in the acquisition of various malignant phenotypes. A hypoxic region is one of the well-known characteristics of solid tumors. Hypoxic cells, which exist in hypoxic regions, are resistant to chemotherapy and radiotherapy. 2, 3) It has been gradually clarified that cancer stem cells, which exist in hypoxic regions in solid tumors, 4) are responsible for radioresistance. 5) These cancer cells are associated with poor prognosis and may be an important target for radiotherapy. Thus, many radiosensitizing agents, such as 2-nitroimidazole, 5-nitroimidazole, and triazole derivatives, have been developed. [6] [7] [8] Only one 5-nitroimidazole derivative, nimorazole, has been used in clinical radiotherapy in Denmark for head and neck cancer. 9) However, many researchers now understand that it is difficult to develop potent radiosensitizers because of poor in vitro-in vivo correlation in the radiosensitivity of cancer cells. To overcome this problem, we attempted to develop an in vivo radiosensitizing evaluation system using tumor-bearing chick embryo. Chick embryo is useful for evaluating drugs. In particular, a retrospective comparative study between the chick embryo assay and the clinical response has reported that the chick embryo assay is useful as a chemosensitivity test to predict the efficacy of anticancer drugs in the treatment of clinical malignant glio-mas and that its overall predictive accuracy is 90%. 10) Chick embryo are also used in research on metastasis, 11) angiogenesis, 12) toxicity, 13) photodynamic therapy, 14) and inflammation.
15) The United States Food and Drug Administration has also approved products preclinically evaluated with chick embryo.
16) The advantages of chick embryo are as follows: (i) Cancer cells are easily implanted to the host without the requirement for first destroying the immune system (as with the severe combined immunodeficiency mouse) since the chick embryo is immunodeficiency by nature; 17) (ii) Special facilities, based on the animal experimentation guidelines, is not required. Chick embryo used for oncology research is not defined as a laboratory animal in guidelines for the handling of laboratory animals (in Japan), because chick embryo can not run away from the research laboratory and all the experiments usually finish until hatching; (iii) For radiosensitizing evaluations using mice, the mice must be fixed to a lab bench under anesthesia, whereas the chick embryo are easily irradiated without the need to perform any cumbersome operations; and (iv) ADME (absorption, distribution, metabolism, and excretion)/Tox (toxicology) properties can be evaluated, because the phase I and II metabolizing enzymes still work in chick embryo. 18) In particular, nitroimidazole metabolism was detected in chick embryo. 19) Thus, there were many possibilities to evaluate hypoxic cell radiosensitizers using tumor-bearing chick embryo.
To the best of our knowledge, the in vivo radiosensitizing activity of radiosensitizers has never been evaluated using tumor-bearing chick embryo. Therefore, we attempted to evaluate the in vivo radiosensitizing activity of etanidazole, which is a well-known hypoxic cell radiosensitizer, in a phase I clinical trial 20) using tumor-bearing chick embryo.
MATERIALS AND METHODS

Chemicals
Etanidazole was synthesized in our laboratory. Liquid paraffin and NaCl of analytical grade were purchased from Wako Pure Chemical Industries Ltd. (Osaka, Japan). Intralipos was purchased from Otsuka Pharmaceutical Co., Ltd. (Tokyo, Japan).
Cell culture
EMT6/KU mouse mammary tumor cells were maintained in Eagle's MEM medium supplemented with 12% fetal bovine serum.
Inoculation of EMT6/KU onto chorioallantoic membrane (CAM)
Fertilized chicken eggs were purchased from the Goto Hatchery, Inc. (Gifu, Japan). The onset-day of the incubation was called day 1. The fertilized chicken eggs were incubated in a humidified incubator at 37.6°C until day 11. On day 11, an egg was candled with halogen light to mark a Y-shaped blood vessel on its CAM. A 2.5 × 2.5 cm square hole was marked around the blood vessels and then cut off with a grinder to make a window. After the eggshell and membrane were removed, the open square window was sealed with polyurethane film (Opsite, Smith & Nephew, London, UK). A Teflon ring was placed on the Y-shaped blood vessels on the CAM and the EMT6/KU mouse mammary cells were inoculated at 2.5 × 10 5 cells/embryo into the Teflon ring. The window was sealed again with 3M Tegaderm TM (3M, St. Paul, MN) transparent polyurethane film, and the chick embryos was incubated at 37.6°C in a humidified atmosphere for 48 hours. After a 48 h EMT6/KU cells inoculation, the Teflon ring was removed and the chick embryo was incubated at 37.6°C in a humidified atmosphere until days 15-19.
X-ray irradiation
On day 15, the chick embryos received a single dose of whole body X-ray irradiation using a 150 kVp X-ray generator (MBR-1520R-3, Hitachi Ltd., Tokyo, Japan. Aluminum 1 mm additional filter) at a dose rate of 4 Gy/min.
Administration of etanidazole
On day 15, an egg was candled with halogen light to mark a thin blood vessel on its CAM. A 0.5 × 2 cm rectangle window was marked around the thin blood vessels to cut off its eggshell with a grinder. To visualize the blood vessels under the membrane, liquid paraffin was dropped onto the eggshell membrane. The intravenous (i.v.) administration of etanidazole in physiological saline (1% Intralipos) was performed with a 30 G needle. The dosage of etanidazole to the weight of the chick embryos was calculated from the average weight of the chick embryos at day 15 (6.51 ± 0.35 g). In radiosensitizing assay, etanidazole was administered i.v. into the CAM vein 10 min before X-ray irradiation. After 24, 48 , and 72 h of X-ray irradiation or i.v. administration, the survival rate of the chick embryos was calculated by the following equation:
Survival rate of chick embryo after X-ray irradiation or i.v. administration of etanidazole
where Ns is the number of surviving chick embryos and Nd is the number of dead chick embryos.
Dissection of the tumor on the CAM
On day 18, the chick embryo was sacrificed and the tumor was dissected from the CAM using scissors. After the surrounding tissues and blood were removed, the tumor weight was measured and photographs were obtained.
The tumor growth suppression rate was calculated using the following equation:
The tumor growth suppression rate = [1 -(Wt/Wc)] × 100 where Wc is the tumor weight of the control and Wt is a tumor weight of treated chick embryos.
Ethical issues
Animal experiments were approved by the animal ethics committees of the University of Tokushima (approval #10020) and carried out in accordance with international care regulations.
Statistical analysis
Data are expressed as mean ± S.D. The significance of the differences between the results of the independent experiments was analyzed using the Student's t-test. A p value of <0.05 was considered to be significant. A Thompson's rejection test was performed for individual values of tumor weight.
RESULTS
Time-dependent changes in tumor weight
It was difficult to distinguish between tumor tissues and surrounding tissues in the day 14 chick embryos, whereas tumor tissues were easily distinguishable in the day 15 ones. The tumor growth gradually increased and reached a plateau in the day 18 chick embryos. The tumor weight values on days 15, 16, 17, 18, and 19 were 36 ± 10, 49 ± 7, 88 ± 26, 103 ± 45, and 111 ± 49 mg, respectively (Fig. 1A) . The tumor appearance at day 15 was solid tumor (Fig. 1B) .
Radiation-induced fatality
To determine the maximal tolerated dose (MTD) of a single treatment with X-ray irradiation, day 15 chick embryos were exposed to X-ray irradiation. Most fatalities occurred within 24 h after their irradiation (Fig. 2) . The survival rate was decreased by X-ray irradiation above 12 Gy. The MTD was 11 Gy and the LD 50 value was 13.3 Gy at 72 h after Xray irradiation. Fig. 2 . Survival rate of chick embryos without tumor-bearing after X-ray irradiation. Day 15 chick embryos without tumor-bearing were irradiated by a whole body X-ray alone. Viability was evaluated at 24, 48, and 72 h after a X-ray irradiation. Ten eggs were used at each dose. 
Tumor growth suppression effect of X-rays
To evaluate the tumor growth suppression effect of a single treatment with X-ray irradiation, the day 15 tumor-bearing chick embryos was irradiated by X-ray. The tumor weights at doses 0, 6, 8, and 10 Gy were 124 ± 49, 94 ± 31, 96 ± 37, and 90 ± 35 mg, respectively (Fig. 3A) . The tumor weight did not significantly decrease at all the doses. The tumor growth suppression rate at doses 6, 8, and 10 Gy were 24, 23, and 27%, respectively. The survival rate at doses 0, 6, 8, and 10 Gy were 77, 83, 100, and 46%, respectively (Fig. 3B) .
Fatality of etanidazole
To determine a non-lethal dose of etanidazole, etanidazole was administrated i.v. to day 15 chick embryos. The survival rates at 72 h after the i.v. administration of 0 mg, 1.0 mg (154 mg/kg), 3.0 mg (461 mg/kg), and 10.0 mg (1536 mg/ kg) of etanidazole were 100, 100, 83, and 8%, respectively (Fig. 4) . A dose of less than 1.0 mg of etanidazole did not have any obvious fatal effects. 3 . Tumor growth suppression and fatality effect of a whole body X-ray irradiation using tumor-bearing chick embryos. (A) A whole body X-ray irradiation was done at day 15 chick embryo and tumor was dissected at day 18 chick embryos and measured tumor weights. The number of eggs was as follows: 0 Gy, 10 eggs; 6 Gy, 9 eggs; 8 Gy, 12 eggs and 10 Gy, 5 eggs. One egg at 6 and 10 Gy of irradiation were rejected by the Thompson's rejection test. Values are mean ± S.D. (B) A whole body X-ray irradiation was done at day 15 chick embryos and viability was evaluated at 72 h after a whole body X-ray irradiation. The number of eggs (surviving eggs/total eggs) was as follows: 0 Gy, (10/13); 6 Gy, (10/12); 8 Gy, (12/12) and 10 Gy, (6/13). 
Tumor growth suppression effect of etanidazole
In vivo radiosensitizing activity of etanidazole
DISCUSSION
It has already been reported that the chick embryo assay enhanced the antitumor activity of ionizing radiation. In this system, cancer cells were treated with para-aminobenzoic acid (PABA) for 7 days in an in vitro culture and then inoculated onto day 10 chick embryos. 21) The irradiation was done at 24 h after inoculation and the tumor growth suppression was evaluated 7 days after inoculation. In our opinion this system most likely involved irradiation of non-solid tumors, because solid tumors are unlikely to form within 24 h after inoculation. In contrast, a new insight of our study is that radiosensitizing activity may be used to evaluate the state of solid tumors on the CAM. In radiosensitizing evaluation of our system, 35% of significant tumor growth suppression rate is obtained only when combination treatment with 8 Gy of irradiation and 1.0 mg of etanidazole was done. We think this tumor growth suppression rate arise from radiosensitizing effect.
Significant tumor growth suppression was demonstrated in the combination treatment with 8 Gy of irradiation and 1.0 mg of etanidazole, while it was not observed in the combination of 1.0 mg of etanidazole and either 4 or 6 Gy of irradiation, respectively (data not shown). The reason why a combination treatment with 8 Gy of irradiation and 1.0 mg of etanidazole showed significant radiosensitizing activity may be due to the short period (3 days) of evaluation. To observe clear differences of tumor growth suppression at shorter periods, a higher dose of X-ray irradiation may be required. Most of damaged chick embryos died within 24 h of X-ray irradiation. These results suggest that the fatalities reflect acute toxicity rather than chronic toxicity.
The advantages of our system are as follows: (i) Dosage of i.v. administration of radiosensitizer can be decreased relative to that used in the mouse in vivo model. In the mouse system it is necessary to administer a high dose of radiosensitizers because of the low accumulation in the tumor. 3) Some radiosensitizers are designed to improve the uptake of the tumor. 7) Thus, for evaluation of radiosensitizers in mice, a high dose, for example 100-200 mg/kg 22) or 1000 mg/ kg, 23) was often used to evaluate the radiosensitizing activity. In the case of our tumor-bearing chick embryos system, we were able to do a similar evaluation by using only 0.3-1 mg of etanidazole, which corresponds to a 46-154 mg/kg; (ii) Chick embryo tolerated a high dose of X-ray irradiation during the evaluation period. The LD 50/3 days of the day 15 chick embryo was 13.3 Gy in our study, while the LD 50/30 days of the mice were about 5-6.3 Gy.
24) The chick embryo were able to be irradiated with a high dose of X-ray under single or multifractionated irradiation; (iii) Cumbersome experimental techniques, such as fixing the experimental animal to a lab bench under anesthesia, are not needed; (iv) The evaluation period is shorter than that of the mouse model. The evaluation period for chick embryos is just 3 days after irradiation. On the other hand, longer periods, for example 21 days 25) and about 40-70 days, 26) are needed to evaluate radiosensitizing activity in mouse models. The disadvantages of our system are as follows: (i) The time-dependent changes of tumor volume were not measured, because the length and width of the tumor under the CAM were not measured in real time. This problem may be resolved by using computerized tomography (CT). CT is used to measure tumor volume in mouse models; 27) (ii) The evaluation period is restricted to a short period because experiments using chick embryo must be finished before the chicks hatch. The hatching period is about 21 days. This problem may be resolved by re-inoculating in the new CAM of another day 10 chick embryos, which would provide a longer period of evaluation than in a case of non-reinoculation. 28) In conclusion, in the present study, we succeeded in evaluating the in vivo radiosensitizing activity of etanidazole using tumor-bearing chick embryo. These results suggest that the use of tumor-bearing chick embryo may be part of a promising system for evaluating radiosensitizing activity. In the future, we will try to evaluate other radiosensitizer using chick embryo as alternative animal experiment.
